Galectin-3 levels in patients with hypertrophic cardiomyopathy and its relationship with left ventricular mass index and function

OBJECTIVE: Cardiac fibrosis is an important contributor to adverse left ventricular (LV) remodeling and arrhythmias in patients with hypertrophic cardiomyopathy (HCM). Galectin-3 (Gal-3) is a novel marker of cardiac fibrosis and inflammation. In this study, we investigated Gal-3 levels in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Tülüce, Selcen Yakar, Tülüce, Kamil, Çil, Zafer, Emren, Sadık Volkan, Akyıldız, Zehra İlke, Ergene, Oktay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2016
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336784/
https://www.ncbi.nlm.nih.gov/pubmed/26488381
http://dx.doi.org/10.5152/AnatolJCardiol.2015.6191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336784/
https://www.ncbi.nlm.nih.gov/pubmed/26488381
http://dx.doi.org/10.5152/AnatolJCardiol.2015.6191

Ejemplares similares